Inicio>>Signaling Pathways>> Apoptosis>> TNF-α>>Gamma-glutamylcysteine (TFA)

Gamma-glutamylcysteine (TFA) (Synonyms: γ-Glutamylcysteine TFA)

Catalog No.GC36106

La gamma-glutamilcisteína (γ-glutamilcisteína) TFA, un intermediario en la síntesis de glutatión (GSH), es un dipéptido que actúa como cofactor esencial para la enzima antioxidante glutatión peroxidasa (GPx).

Products are for research use only. Not for human use. We do not sell to patients.

Gamma-glutamylcysteine (TFA) Chemical Structure

Cas No.: 283159-88-6

Tamaño Precio Disponibilidad Cantidad
1mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Gamma-glutamylcysteine (TFA) ((γ-glutamylcysteine (TFA)), an intermediate in glutathione (GSH) synthesis, is a dipeptide served as an essential cofactor for the antioxidant enzyme glutathione peroxidase (GPx). Gamma-glutamylcysteine (TFA) also upregulates the level of the anti-inflammatory cytokine IL-10 and reduces the levels of the pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) and attenuates the changes in metalloproteinase activity in oligomeric Aβ40-treated astrocytes[1]. IL-10 IL-6 IL-1β TNF-α

[1]. Braidy N, et al. The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ40 Oligomers in Human Astrocytes. Front Aging Neurosci. 2019 Aug 8;11:177.

Reseñas

Review for Gamma-glutamylcysteine (TFA)

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Gamma-glutamylcysteine (TFA)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.